Richard Barker joins Molecular Staging of New Haven, Conn., as executive chairman of the board of directors. Previously, he was CEO of Chiron Diagnostics and general manager of IBM’s health care solutions business. Barker holds a BA in chemistry and a doctorate in biophysics from the University of Oxford in England.
James Meade has been named vice president of business development at Avalon Pharmaceuticals, and Paul Young has been promoted to vice president of research at the company. Meade comes to Avalon from Pfizer/Pharmacia where he worked in global licensing of anti-infective and urology products. Young was most recently senior scientific director of discovery biology at Avalon, and a member of its scientific management committee.
Ambion announced that John Dahler has been named chief financial officer, effective Feb. 2.
John Dahler has approximately 20 years experience in accounting and finance, most recently with Promega.
Stanley Fields, Richard Morimoto, Gregory Reyes, and Virginia Zakian join the National Advisory General Medical Sciences Council. Fields is a professor of genome sciences and medicine at the University of Washington, where he also serves as an adjunct professor of microbiology and a Howard Hughes Medical Institute investigator. Morimoto is dean of the graduate school and a professor in the department of biochemistry, molecular biology, and cell biology at Northwestern University. Reyes recently retired from his position as vice president of biological research, infectious diseases, oncology, and gene therapy at the Schering-Plough Research Institute. Zakian is a professor of molecular biology at Princeton University.